Physician

Peter A Zeman, M.D.

According to 2025 Medicare claims, Peter Zeman, M.D. (NPI: 1730173287) practices urology in the Wilmington, NC market, with the plurality of this provider's patient population coming from New Hanover, NC. This provider's primary affiliated billing organization is UROLOGY ASSOCIATES OF SOUTHEASTERN NORTH CAROLINA, PA (NPI: 1407875610; TIN: 561274107) and primary practice location at 28403-6024. Zeman is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Zeman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,106 traditional Medicare patients, billed 20,494 HCPCS/CPT codes, and received $870,498 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,816 prescription claims across 582 beneficiaries totaling $8,486,283 in drug costs, led by Xtandi (Enzalutamide). DME data shows 49 claims. Open Payments data shows 149 records totaling $3,388. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $286,501 to $870,498. Similarly, Part D prescription costs have moved sharply higher in recent years, from $130,651 to $8,486,283. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $1,588 to $563.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	906	16,949	$286,501
2016	929	14,917	$338,930
2017	957	16,597	$369,083
2018	885	11,954	$584,422
2019	880	15,921	$279,649
2020	871	15,029	$366,181
2021	990	21,953	$651,065
2022	1,178	17,950	$992,282
2023	1,231	19,271	$767,702
2024	1,106	20,494	$870,498

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	256	1,140	$130,651
2016	261	1,162	$138,298
2017	269	1,084	$98,977
2018	263	1,082	$209,826
2019	329	1,173	$356,775
2020	371	1,355	$644,823
2021	441	1,908	$3,121,223
2022	500	2,424	$4,955,666
2023	551	2,605	$6,582,555
2024	582	2,816	$8,486,283

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	152	$34,671
2016	11	162	$29,962
2017	11	213	$34,452
2018	N/R	197	$31,181
2019	N/R	155	$31,729
2020	N/R	140	$44,102
2021	N/R	113	$49,453
2022	N/R	76	$34,816
2023	N/R	92	$24,755
2024	N/R	49	$8,171

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	827	1,266	$82
84153	Psa (prostate specific antigen) measurement, total	510	699	$18
36415	Insertion of needle into vein for collection of blood sample	504	693	$9
51798	Ultrasound measurement of bladder capacity after voiding	269	372	$8
81002	Urinalysis, manual test	846	1,267	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	482	14,460	$6,478,425
Erleada	Apalutamide	45	1,350	$636,402
Nubeqa	Darolutamide	31	930	$411,177
Orgovyx	Relugolix	136	4,080	$346,751
Trelstar	Triptorelin Pamoate	62	10,200	$294,503

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	25	$5,406
A4392	Ostomy pouch, urinary, with standard wear barrier attached, with built-in convexity (1 piece), each	N	N/R	12	$1,997
A4362	Skin barrier; solid, 4 x 4 or equivalent; each	N	N/R	12	$768

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	149	$3,388	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Peter A. Zeman, M.D.?

Tedicare shows public-source Medicare data for Peter A. Zeman, M.D. (NPI 1730173287), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter A. Zeman, M.D. have ACO affiliation data?

Peter A. Zeman, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Peter A. Zeman, M.D.?

Peter A. Zeman, M.D. is linked to UROLOGY ASSOCIATES OF SOUTHEASTERN NORTH CAROLINA, PA (billing NPI 1407875610) in the available physician profile data.

Does Peter A. Zeman, M.D. have Open Payments data?

Peter A. Zeman, M.D. has 149 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.